title: Vaccines based on novel adeno-associated virus vectors elicit aberrant CD8+ T-cell responses in mice.
abstract: We recently discovered an expanded family of adeno-associated viruses (AAVs) that show promise as improved gene therapy vectors. In this study we evaluated the potential of vectors based on several of these novel AAVs as vaccine carriers for human immunodeficiency virus type 1 Gag. Studies with mice indicated that vectors based on AAV type 7 (AAV7), AAV8, and AAV9 demonstrate improved immunogenicity in terms of Gag CD8(+) T-cell and Gag antibody responses. The quality of these antigen-specific responses was evaluated in detail for AAV2/8 vectors and compared to results with an adenovirus vector expressing Gag (AdC7). AAV2/8 produced a vibrant CD8(+) T-cell effector response characterized by coexpression of gamma interferon and tumor necrosis factor alpha as well as in vivo cytolytic activity. No CD8(+) T-cell response generated by any of the AAVs was effectively boosted with AdC7, a result consistent with the finding of a relative lack of cells expressing interleukin-2 (IL-2) or a central memory phenotype at 3 months after the prime. The primary response to an AdC7 vaccine differed from that generated by AAVs in that the peak effector response evolved into populations of Gag-specific T cells expressing high levels of cytokines, including IL-2, and with effector memory and central memory phenotypes. A number of mechanisms could be considered to explain the aberrant activation of CD8(+) T cells by AAV, including insufficient inflammatory responses, CD4 help, and/or chronic antigen expression and T-cell exhaustion. Interestingly, the B-cell response to AAV-encoded Gag was quite vibrant and easily boosted with AdC7.
authors: Gene Therapy Program, Department of Pathology and Laboratory Medicine, University of Pennsylvania, 125 S. 31st Street, Philadelphia, PA 19104-3403, USA.
authors: Jianping
authors: J
authors: Lin
authors: Yan
authors: Y
authors: Zhi
authors: Lauren
authors: L
authors: Mays
authors: James M
authors: JM
authors: Wilson
mesh_terms: D016915:AIDS Vaccines / Q000737:chemistry; D000818:Animals; D001402:B-Lymphocytes / Q000378:metabolism; D018414:CD8-Positive T-Lymphocytes / Q000378:metabolism*; D000229:Dependovirus / Q000235:genetics*; D015683:Gene Products, gag / Q000378:metabolism; D005822:Genetic Vectors; D015658:HIV Infections / Q000517:prevention & control; D015497:HIV-1 / Q000378:metabolism; D007376:Interleukin-2 / Q000378:metabolism; D008099:Liver / Q000821:virology; D008168:Lung / Q000821:virology; D051379:Mice; D008807:Mice, Inbred BALB C; D008810:Mice, Inbred C57BL; D014409:Tumor Necrosis Factor-alpha / Q000378:metabolism
chemical_list: D016915:AIDS Vaccines; D015683:Gene Products, gag; D007376:Interleukin-2; D014409:Tumor Necrosis Factor-alpha
references: Nature. 2002 Jan 17;415(6869):331-5
references: 11797011
references: Infect Immun. 2005 Sep;73(9):5809-16
references: 16113299
references: J Virol. 1998 Jan;72(1):309-19
references: 9420229
references: J Virol. 2002 May;76(9):4580-90
references: 11932423
references: Curr Gene Ther. 2005 Jun;5(3):323-31
references: 15975009
references: Expert Rev Vaccines. 2004 Aug;3(4 Suppl):S33-52
references: 15285704
references: J Virol. 2007 Apr;81(7):3170-80
references: 17229689
references: Nature. 2003 Feb 20;421(6925):852-6
references: 12594515
references: Blood. 2004 Aug 15;104(4):969-77
references: 15105293
references: Science. 2003 Apr 11;300(5617):337-9
references: 12690201
references: J Clin Invest. 2003 May;111(9):1347-56
references: 12727926
references: Hum Gene Ther. 2002 Sep 1;13(13):1571-81
references: 12228012
references: J Virol. 2005 Jan;79(2):955-65
references: 15613324
references: Virology. 1984 Apr 15;134(1):52-63
references: 6324476
references: J HIV Ther. 2002 May;7(2):35-9
references: 12553686
references: Proc Natl Acad Sci U S A. 2003 May 13;100(10):6081-6
references: 12716974
references: J Immunol. 2005 Oct 1;175(7):4686-96
references: 16177116
references: J Virol. 1999 Feb;73(2):939-47
references: 9882294
references: J Virol. 2003 Jun;77(12):6995-7006
references: 12768018
references: Proc Natl Acad Sci U S A. 1966 Jun;55(6):1467-74
references: 5227666
references: Blood. 2005 Jun 1;105(11):4226-34
references: 15713796
references: Blood. 2005 Apr 15;105(8):3079-86
references: 15637142
references: J Virol. 2001 Dec;75(23):11603-13
references: 11689642
references: Mol Ther. 2006 Feb;13(2):260-9
references: 16324888
references: Proc Natl Acad Sci U S A. 2002 Sep 3;99(18):11854-9
references: 12192090
references: J Gen Virol. 2003 Jan;84(Pt 1):203-13
references: 12533717
references: J Virol. 2003 Apr;77(8):4911-27
references: 12663797
references: J Immunol. 1998 Sep 15;161(6):2985-93
references: 9743362
references: Blood. 2007 Aug 15;110(4):1132-40
references: 17438084
references: Nat Med. 2003 Jul;9(7):874-80
references: 12835708
references: J Virol. 2003 Jul;77(13):7663-8
references: 12805466
references: Science. 2000 Feb 25;287(5457):1453-60
references: 10688787
references: J Virol. 1997 Oct;71(10):7960-2
references: 9311887
references: J Virol. 2004 Jun;78(12):6381-8
references: 15163731
references: Annu Rev Med. 2004;55:355-72
references: 14746526
references: Hum Gene Ther. 2001 Jun 10;12(9):1047-61
references: 11399227
references: J Virol. 2000 Mar;74(6):2888-94
references: 10684306
references: J Virol. 2006 Dec;80(24):11899-910
references: 17005662
references: J Bacteriol. 1965 Jul;90(1):271-4
references: 16562029
references: J Gene Med. 2001 May-Jun;3(3):260-70
references: 11437331
references: Hum Gene Ther. 1997 Nov 1;8(16):1891-900
references: 9382955
references: AIDS Rev. 2003 Jul-Sep;5(3):131-9
references: 14598562
references: Virology. 1984 Apr 15;134(1):64-71
references: 6200995
references: Science. 1965 Aug 13;149(3685):754-6
references: 14325163